skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Hematology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia
The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia

Stein, Eytan M. ; Garcia-Manero, Guillermo ; Rizzieri, David A. ; Tibes, Raoul ; Berdeja, Jesus G. ; Savona, Michael R. ; Jongen-Lavrenic, Mojca ; Altman, Jessica K. ; Thomson, Blythe ; Blakemore, Stephen J. ; Daigle, Scott R. ; Waters, Nigel J. ; Suttle, A. Benjamin ; Clawson, Alicia ; Pollock, Roy ; Krivtsov, Andrei ; Armstrong, Scott A. ; DiMartino, Jorge ; Hedrick, Eric ; Löwenberg, Bob ; Tallman, Martin S.

Blood, 2018-06, Vol.131 (24), p.2661-2669 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis

KHOURY, H. J ; KUKREJA, M ; GALE, R. P ; MARKS, D. I ; MCCARTHY, P. L ; WOOLFREY, A ; SZER, J ; GIRALT, S. A ; MAZIARZ, R. T ; CORTES, J ; HOROWITZ, M. M ; LEE, S. J ; GOLDMAN, J. M ; WANG, T ; HALTER, J ; ARORA, M ; GUPTA, V ; RIZZIERI, D. A ; GEORGE, B ; KEATING, A

Bone marrow transplantation (Basingstoke), 2012-06, Vol.47 (6), p.810-816 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment

KANDA, J ; KAYNAR, L ; GASPARETTO, C ; CHUTE, J. P ; MORRIS, A ; WINKEL, S ; MCPHERSON, J ; KURTZBERG, J ; CHAO, N. J ; HORWITZ, M. E ; KANDA, Y ; PRASAD, V. K ; PARIKH, S. H ; LAN, L ; SHEN, T ; RIZZIERI, D. A ; LONG, G. D ; SULLIVAN, K. M

Bone marrow transplantation (Basingstoke), 2013-07, Vol.48 (7), p.926-931 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study
Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study

Issa, Jean-Pierre J, Prof ; Roboz, Gail, Prof ; Rizzieri, David, Prof ; Jabbour, Elias, MD ; Stock, Wendy, Prof ; O'Connell, Casey, MD ; Yee, Karen, MD ; Tibes, Raoul, MD ; Griffiths, Elizabeth A, MD ; Walsh, Katherine, MD ; Daver, Naval, MD ; Chung, Woonbok, PhD ; Naim, Sue, BS ; Taverna, Pietro, PhD ; Oganesian, Aram, PhD ; Hao, Yong, MD ; Lowder, James N, MD ; Azab, Mohammad, MD ; Kantarjian, Hagop, Prof

The lancet oncology, 2015-09, Vol.16 (9), p.1099-1110 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Use of tamibarotene, a potent and selective RARα agonist, in combination with azacitidine in patients with relapsed and refractory AML with RARA gene overexpression
Use of tamibarotene, a potent and selective RARα agonist, in combination with azacitidine in patients with relapsed and refractory AML with RARA gene overexpression
Material Type:
Artigo 		Adicionar ao Meu Espaço

Use of tamibarotene, a potent and selective RARα agonist, in combination with azacitidine in patients with relapsed and refractory AML with RARA gene overexpression

Stein, Eytan M ; de Botton, Stephane ; Cluzeau, Thomas ; Pigneux, Arnaud ; Liesveld, Jane L ; Cook, Rachel J ; Rousselot, Philippe ; Rizzieri, David A ; Braun, Thorsten ; Roboz, Gail J ; Lebon, Delphine ; Heiblig, Mael ; Baker, Kristen ; Volkert, Angela ; Paul, Sofia ; Rajagopal, Nisha ; Roth, David A ; Kelly, Michael ; Peterlin, Pierre

Leukemia & lymphoma, 2023-12, Vol.64 (12), p.1992-2001 [Periódico revisado por pares]

United States: Taylor & Francis

Texto completo disponível

Citações Citado por
6
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia, stem cells
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia, stem cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia, stem cells

JORDAN, C. T ; UPCHURCH, D ; LUGER, S. M ; PHILLIPS, G. L ; SZILVASSY, S. J ; GUZMAN, M. L ; HOWARD, D. S ; PETTIGREW, A. L ; MEYERROSE, T ; ROSSI, R ; GRIMES, B ; RIZZIERI, D. A

Leukemia, 2000-10, Vol.14 (10), p.1777-1784 [Periódico revisado por pares]

London: Nature Publishing

Texto completo disponível

Citações Citado por
7
Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration
Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration
Material Type:
Artigo 		Adicionar ao Meu Espaço

Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration

HORWITZ, M. E ; CHUTE, J. P ; GASPARETTO, C ; LONG, G. D ; MCDONALD, C ; MORRIS, A ; RIZZIERI, D. A ; SULLIVAN, K. M ; CHAO, N. J

Bone marrow transplantation (Basingstoke), 2012-08, Vol.47 (8), p.1051-1055 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Patterns of microRNA expression characterize stages of human B-cell differentiation
Patterns of microRNA expression characterize stages of human B-cell differentiation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Patterns of microRNA expression characterize stages of human B-cell differentiation

Zhang, Jenny ; Jima, Dereje D. ; Jacobs, Cassandra ; Fischer, Randy ; Gottwein, Eva ; Huang, Grace ; Lugar, Patricia L. ; Lagoo, Anand S. ; Rizzieri, David A. ; Friedman, Daphne R. ; Weinberg, J. Brice ; Lipsky, Peter E. ; Dave, Sandeep S.

Blood, 2009-05, Vol.113 (19), p.4586-4594 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
9
The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD
The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD
Material Type:
Artigo 		Adicionar ao Meu Espaço

The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD

Markey, Kate A. ; Schluter, Jonas ; Gomes, Antonio L.C. ; Littmann, Eric R. ; Pickard, Amanda J. ; Taylor, Bradford P. ; Giardina, Paul A. ; Weber, Daniela ; Dai, Anqi ; Docampo, Melissa D. ; Armijo, Gabriel K. ; Slingerland, Ann E. ; Slingerland, John B. ; Nichols, Katherine B. ; Brereton, Daniel G. ; Clurman, Annelie G. ; Ramos, Ruben J. ; Rao, Arka ; Bush, Amy ; Bohannon, Lauren ; Covington, Megan ; Lew, Meagan V. ; Rizzieri, David A. ; Chao, Nelson ; Maloy, Molly ; Cho, Christina ; Politikos, Ioannis ; Giralt, Sergio ; Taur, Ying ; Pamer, Eric G. ; Holler, Ernst ; Perales, Miguel-Angel ; Ponce, Doris M. ; Devlin, Sean M. ; Xavier, Joao ; Sung, Anthony D. ; Peled, Jonathan U. ; Cross, Justin R. ; van den Brink, Marcel R.M.

Blood, 2020-07, Vol.136 (1), p.130-136 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
10
MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia
MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia

Giles, F J ; Swords, R T ; Nagler, A ; Hochhaus, A ; Ottmann, O G ; Rizzieri, D A ; Talpaz, M ; Clark, J ; Watson, P ; Xiao, A ; Zhao, B ; Bergstrom, D ; Le Coutre, P D ; Freedman, S J ; Cortes, J E

Leukemia, 2013-01, Vol.27 (1), p.113-117 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (62)

Data de Publicação 

De até
Refinar
  1. Antes de2002  (7)
  2. 2002Até2006  (10)
  3. 2007Até2011  (21)
  4. 2012Até2018  (31)
  5. Após 2018  (23)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.